Status:
COMPLETED
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
Lead Sponsor:
Allergan
Conditions:
Intermediate Uveitis
Posterior Uveitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious intermediate or posterior uveitis.
Eligibility Criteria
Inclusion
- 18 years or older with a diagnosis of chronic intermediate uveitis in at least one eye
Exclusion
- Uncontrolled systemic disease
- Any active ocular infections
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
229 Patients enrolled
Trial Details
Trial ID
NCT00333814
Start Date
May 1 2006
End Date
April 1 2009
Last Update
April 14 2011
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Dallas, Texas, United States
2
Sydney, Australia
3
Vienna, Austria
4
São Paulo, São Paulo/SP, Brazil